论文部分内容阅读
观察奥沙利铂(L-OHP)联合方案治疗老年非小细胞肺癌(NSCLC)之近期疗效及毒副反应。结果显示,该方案治疗NSCLC疗效确切,不良反应轻,患者耐受性良好。
To observe the short-term efficacy and toxicity of oxaliplatin (L-OHP) combined treatment for elderly patients with non-small cell lung cancer (NSCLC). The results showed that the program has a definite curative effect on NSCLC, with mild adverse reactions and good patient tolerance.